Angel News

Angel News

Back to Homepage

30th May 2018

TxCell to present its latest manufacturing process achievements


TxCell SA, a developer of cellular immunotherapies based on regulatory T cells (Tregs) for inflammation, autoimmunity and transplantation, today announces it will present its latest manufacturing developments at the 3rd Annual Bioprocessing of Advanced Cellular Therapies Congress to be held in Frankfurt, Germany, on May 29-30, 2018. 



Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage